Doctors Note Logo

Published on: 5/22/2026

Navigating the Cost of Dupixent for CRSwNP: Patient Copay Programs

Dupixent for CRSwNP costs roughly $3,100 per two-mL syringe and insurance copays can range from $50 to over $1,000 per injection depending on your plan’s formulary, deductibles and specialty pharmacy use. Assistance programs such as Sanofi MyWay, independent patient foundations, manufacturer savings cards and strategic tips like mail-order pharmacies can significantly lower out-of-pocket expenses.

There are several factors to consider when planning your next steps in care, including eligibility criteria, application tips and timing strategies; see below for complete details to guide your decision.

answer background

Explanation

Navigating the Cost of Dupixent for CRSwNP: Patient Copay Programs

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) affects thousands of people, causing persistent nasal congestion, loss of smell, facial pressure and recurrent infections. Dupixent® (dupilumab) has emerged as an effective biologic therapy to control symptoms and reduce polyp size. However, the cost of Dupixent for CRSwNP can be a barrier. This guide outlines practical steps, assistance programs and resources to help you manage out-of-pocket expenses without increasing stress.

Understanding the Cost of Dupixent for CRSwNP

  • List Price
    • Each two-mL syringe of Dupixent has a wholesale acquisition cost of approximately $3,100–$3,200.
    • Most patients require one injection every two weeks after an initial loading dose.

  • Insurance Coverage Variability
    • Private health plans, Medicare Part B or D and Medicaid may cover Dupixent differently.
    • Coverage depends on formulary status, step-therapy requirements and prior authorization rules.
    • Even with insurance, copays or coinsurance can range from $50 to over $1,000 per injection.

  • Factors Affecting Your Cost
    • Plan deductible and out-of-pocket maximum
    • Pharmacy benefit manager (PBM) protocols
    • In-network vs. out-of-network specialty pharmacies

Copay Assistance Options

1. Sanofi Patient Assistance Program (Sanofi MyWay®)

Sanofi, the manufacturer of Dupixent, offers the Sanofi MyWay® program to help eligible individuals reduce or eliminate copays.

  • Eligibility Criteria
    • U.S. resident with commercial insurance
    • Annual household income up to $100,000 (up to $150,000 for multi-person households)
    • Confirmation of insurance coverage and FDA-approved indication

  • Benefits
    • Copay assistance up to $10,000 per calendar year
    • Coordination with your specialty pharmacy for streamlined billing

  • How to Apply

    1. Visit the Sanofi MyWay® website or call their dedicated helpline.
    2. Submit proof of income, insurance card and physician prescription.
    3. Receive an approval letter you share with your specialty pharmacy.

2. Independent Patient Assistance Foundations

If you have limited or no insurance coverage, not all programs may apply. Independent foundations can help cover out-of-pocket costs:

  • HealthWell Foundation
    • Offers grants for biologic therapies, including Dupixent
    • Income-based assistance

  • Patient Advocate Foundation
    • Case management and financial aid for copays and deductibles
    • Eligibility varies by program

  • NeedyMeds and RxAssist
    • Online directories of assistance programs by medication
    • Application guidance

3. Manufacturer Savings Cards

If your insurance plan places Dupixent on a high tier, a savings card from Sanofi can reduce copays:

  • Typically lowers your copay to $0–$25 per injection
  • Available only to commercially insured patients
  • Not valid for cash-paying or government-insured (Medicare/Medicaid) patients

Strategies to Minimize Out-of-Pocket Costs

  1. Verify Formulary Status
    • Contact your insurer or PBM to confirm whether Dupixent is on the preferred drug list.
    • Ask if prior authorization or step therapy is required.

  2. Use Specialty Pharmacies
    • Specialty pharmacies have experience navigating benefit coordination and copay programs.
    • They can assist with faster prior authorizations and appeals.

  3. Explore Alternative Coverage
    • If uninsured or underinsured, consider state Medicaid programs or Affordable Care Act (ACA) marketplace plans.
    • Check if you qualify for Medicare Extra Help (Low-Income Subsidy) to reduce Part D costs.

  4. Request a Financial Navigator
    • Many hospitals, clinics and nonprofit organizations employ financial navigators.
    • They can guide you through paperwork and identify additional aid.

  5. Mail-Order vs. Retail Pharmacy
    • Mail-order specialty pharmacies may offer lower copays for 90-day supplies, if approved.
    • Compare costs between local specialty pharmacies and national mail-order options.

  6. Plan for Deductible Seasons
    • If you meet your annual deductible early in the year, copays may drop afterward.
    • Strategize the timing of your first injection to maximize deductible benefits.

Tips for a Smooth Application Process

  • Gather Documentation Early: Proof of income, insurance info, prescription details and a recent medical record noting your CRSwNP diagnosis.
  • Work Closely with Your Healthcare Team: Physicians and nurses can submit prior authorizations and appeals letters supporting medical necessity.
  • Keep Detailed Records: Track submission dates, reference numbers and correspondence with foundations or insurers.
  • Follow Up Regularly: Check application status every 2–4 weeks to prevent delays.
  • Appeal Denials Quickly: If coverage is denied, request an internal appeal and appeal with your insurer's external review board if needed.

Managing Emotional Well-being

While navigating insurance forms and financial aid can feel overwhelming, take steps to maintain balance:

  • Break tasks into small, manageable steps.
  • Lean on family, friends or support groups for encouragement.
  • Discuss cost concerns openly with your care team; they've guided many patients through similar challenges.

When to Consider Additional Medical Advice

If your CRSwNP symptoms worsen—such as severe facial pain, sudden vision changes or signs of infection—seek medical attention promptly. You can also use a Medically approved LLM Symptom Checker Chat Bot to quickly evaluate your symptoms and determine whether you need urgent care or if your concerns can wait for a scheduled appointment.

Final Thoughts

Understanding the cost of Dupixent for CRSwNP and accessing copay assistance doesn't have to be a solo journey. By leveraging manufacturer programs, independent foundations and strategic planning, you can reduce your financial burden and focus on getting symptom relief.

Always discuss any serious or life-threatening concerns with your doctor. Their guidance is essential in choosing the safest, most effective treatment plan for you.

(References)

  • * Del Prete, L., Di Perna, G., Passali, G. C., Costi, S., Turetta, V., & Costi, M. (2022). The economic burden of chronic rhinosinusitis with nasal polyps: A systematic review. *Rhinology*, 60(2), 77–90. PubMed: https://pubmed.ncbi.nlm.nih.gov/34293976/

  • * Schauer, A., White, M., Stull, C., & Yancey, K. S. (2021). Cost-effectiveness of dupilumab for the treatment of chronic rhinosinusitis with nasal polyps in the United States. *Journal of Managed Care & Specialty Pharmacy*, 27(11), 1546–1554. PubMed: https://pubmed.ncbi.nlm.nih.gov/34685718/

  • * Braddock, J. S., Biskupiak, J. E., & Darden, P. (2020). Patient and Physician Perspectives on Access Barriers to Biologic Therapies for Allergic and Immunologic Diseases. *Journal of Managed Care & Specialty Pharmacy*, 26(10), 1307–1316. PubMed: https://pubmed.ncbi.nlm.nih.gov/33058869/

  • * Stull, C., Schauer, A., White, M., & Yancey, K. S. (2023). Real-World Healthcare Resource Utilization and Costs for Patients with Chronic Rhinosinusitis with Nasal Polyps in the US. *Journal of Managed Care & Specialty Pharmacy*, 29(4), 408–417. PubMed: https://pubmed.ncbi.nlm.nih.gov/36979219/

  • * Bachert, C., Pfaar, O., & Mullol, J. (2021). Dupilumab in chronic rhinosinusitis with nasal polyps: A review of its role and value. *Allergy and Asthma Proceedings*, 42(5), 450–459. PubMed: https://pubmed.ncbi.nlm.nih.gov/34521404/

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.